Principles of gene therapy: Prospects for the treatment of head and neck cancer

Journal of Laryngology and Otology

Volumn 112, Issue 10, 1998, Pages 913-920

  Green, Nicola K ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; ALKYLATING AGENT; ANTIVIRUS AGENT; FLUCYTOSINE; FLUOROURACIL; GANCICLOVIR; GANCICLOVIR CYCLIC PHOSPHATE; PLASMID VECTOR; PRODRUG; TUMOR PROMOTER; TUMOR VACCINE;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CYTOLYSIS; DNA SYNTHESIS INHIBITION; ENZYME ACTIVATION; GENE EXPRESSION; GENE INSERTION; GENE TARGETING; GENE THERAPY; HEAD AND NECK CANCER; HERPES SIMPLEX VIRUS; HUMAN; RETROVIRUS; TUMOR SUPPRESSOR GENE;

EID: 0031668817     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022215100142082     Document Type: Article

References (2)

1. Anlezark, G. M., Melton, R. G., Sherwood, R. F., Coles, B., Friedlos, F., Knox, R. J. (1992) The bioactivation of CB 1954. I. Purification and properties of a nitroreductase enzyme from Escherichia coli - a potential enzyme for antibody directed enzyme therapy (ADEPT). Biochemical Pharmacology 44: 2289-2295.
2. Bischoff, J. R., Kirn, D. H., Williams, A., Heise, C, Horn, S., Muna, M., Ng, L., Nye, J. A., Sampson-Johannes, A., Fallacy, A. McCormick, F. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376.